SETD2 and nonpapillary renal cell carcinoma: We further excluded a total of 146 and 262 samples for downstream analysis because they carried mutations in five high-confidence ccRCC driver genes (VHL, BAP1, SETD2, PTEN, and KDM5C) [13, 15].